MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
56.75%
Cash Ratio
17.48%
Debt to Asset Ratio
127.27%
Unit: Thousand (K) dollars
Assets Breakdown
    • Receivable for cash held back fr...
    • Cash and cash equivalents
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Promissory notes, net
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
900
1,195
1,303
2,137
Accounts receivable, net
-
-
-
3,498
Non-trade receivable
-
-
-
9,841
Inventory
-
-
-
10,986
Receivable for cash held back from the asset sale
1,248
1,500
-
-
Receivable, related party
15
-
-
-
Prepaid expenses and other current assets
759
608
676
3,839
Current assets held for sale
-
-
26,930
-
Total current assets
2,922
3,303
28,909
30,301
Property and equipment, net
-
-
-
140
Investment in dna x llc under equity method
-
1,290
1,242
-
Contract fulfillment assets
-
-
-
9,053
Deferred tax assets
-
-
1,441
-
Identifiable intangible assets
1,379
-
-
-
Other assets
216
245
274
725
Non-current assets held for sale
-
-
12,032
-
Total assets
4,517
4,838
43,898
40,219
Accounts payable
683
719
4,030
20,408
Accrued liabilities
960
1,576
704
13,631
Promissory notes, net
2,400
1,072
5,065
4,817
Derivative liability
797
398
171
-
Current liabilities held for sale
-
-
38,057
-
Income tax payable
309
556
-
-
Total current liabilities
5,149
4,321
48,027
38,856
Promissory notes, net
-
-
-
250
Income tax payable
-
-
2,598
1,814
Deferred tax liability
600
600
-
-
Total liabilities
5,749
4,921
50,625
40,920
Redeemable common stock 0.001 par value 223,201 shares issued and outstanding redemption value 900 at march 31, 2026 and 1,228 as of december 31, 2025 (note 6)
-
900
1,228
-
Common stock, 0.001 par value per share 1,000,000,000 shares authorized and 1,488,268 and 1,265,067 shares issued and outstanding at june 30, 2026 and december 31, 2025 respectively
1
1
1
1
Additional paid-in capital
297,674
296,613
296,309
294,676
Accumulated deficit
-298,907
-297,597
-304,265
-295,378
Total stockholders deficit
-1,232
-983
-7,955
-701
Total liabilities, redeemable common stock, and stockholders deficit
4,517
4,838
43,898
40,219
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Receivable for cash heldback from the asset...$1,248K Cash and cashequivalents$900K (-55.13%↓ Y/Y)Prepaid expenses andother current assets$759K (-85.43%↓ Y/Y)Receivable, related party$15K Total current assets$2,922K (-89.23%↓ Y/Y)Identifiable intangibleassets$1,379K Other assets$216K (-72.31%↓ Y/Y)Total assets$4,517K (-87.48%↓ Y/Y)Accumulated deficit-$298,907K (-2.85%↓ Y/Y)Total liabilities,redeemable common stock,...$4,517K (-87.48%↓ Y/Y)Total stockholdersdeficit-$1,232K (7.65%↑ Y/Y)Additional paid-in capital$297,674K (2.90%↑ Y/Y)Common stock, 0.001 parvalue per share...$1K (-90.00%↓ Y/Y)Total liabilities$5,749K (-84.63%↓ Y/Y)Total currentliabilities$5,149K (-85.56%↓ Y/Y)Deferred tax liability$600K Promissory notes, net$2,400K Accrued liabilities$960K (-92.11%↓ Y/Y)Derivative liability$797K Accounts payable$683K (-96.68%↓ Y/Y)Income tax payable$309K (-82.34%↓ Y/Y)

DNA X, Inc. (SONM)

DNA X, Inc. (SONM)